-+ 0.00%
-+ 0.00%
-+ 0.00%

AVALO THERAPEUTICS INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $38

Reuters·07/06/2026 10:52:56

Please log in to view news